Sexual dysfunction prevalence rates: marketing or real?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18978094)

Published in Obstet Gynecol on November 01, 2008

Authors

Ingrid Nygaard

Articles cited by this

Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol (2008) 3.41

Articles by these authors

Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med (2010) 7.95

Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med (2006) 7.42

Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol (2002) 5.73

A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59

Defining success after surgery for pelvic organ prolapse. Obstet Gynecol (2009) 3.46

Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol (2007) 3.16

A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med (2012) 2.90

Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence. Obstet Gynecol (2008) 2.58

Fecal and urinary incontinence in primiparous women. Obstet Gynecol (2006) 2.28

Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med (2012) 2.03

Abdominal pain, bloating, and urgency. Obstet Gynecol (2005) 2.02

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol (2005) 2.01

A randomized trial of colpopexy and urinary reduction efforts (CARE): design and methods. Control Clin Trials (2003) 1.93

Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol (2008) 1.85

The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol (2009) 1.73

The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.64

Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynecol J (2014) 1.61

The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics and quality of life. J Urol (2009) 1.55

Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery. J Urol (2011) 1.53

Flushing and papules in a middle-aged woman. Obstet Gynecol (2005) 1.38

Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol (2003) 1.37

Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods. Clin Trials (2009) 1.24

Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn (2011) 1.21

Pelvic organ support among primiparous women in the first year after childbirth. Int Urogynecol J Pelvic Floor Dysfunct (2009) 1.10

Comparison of mindfulness-based stress reduction versus yoga on urinary urge incontinence: a randomized pilot study. with 6-month and 1-year follow-up visits. Female Pelvic Med Reconstr Surg (2014) 1.05

Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial. Contemp Clin Trials (2011) 1.04

Risk factors for fecal and urinary incontinence after childbirth: the childbirth and pelvic symptoms study. Am J Gastroenterol (2007) 1.03

Minimum important difference for validated instruments in women with urge incontinence. Neurourol Urodyn (2011) 1.01

Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years. Obstet Gynecol (2005) 1.01

Sexual function before and after sacrocolpopexy for pelvic organ prolapse. Am J Obstet Gynecol (2007) 0.98

Web versus paper-based completion of the epidemiology of prolapse and incontinence questionnaire. Female Pelvic Med Reconstr Surg (2013) 0.96

Quantification of vaginal support: are continuous summary scores better than POPQ stage? Am J Obstet Gynecol (2010) 0.93

Childbirth and pelvic floor disorders. Clin Obstet Gynecol (2004) 0.93

Anorectal dysfunction after surgical treatment for cervical cancer. J Am Coll Surg (2002) 0.92

Incontinence pessaries: size, POPQ measures, and successful fitting. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.87

Enhancing participation of older women in surgical trials. J Am Coll Surg (2008) 0.87

Muscular fatigue in the pelvic floor muscles after strenuous physical activity. Acta Obstet Gynecol Scand (2007) 0.87

Long-term follow-up of treatment for synthetic mesh complications. Female Pelvic Med Reconstr Surg (2014) 0.86

Can women correctly contract their pelvic floor muscles without formal instruction? Female Pelvic Med Reconstr Surg (2013) 0.85

Sexual function before and after non-surgical treatment for stress urinary incontinence. Female Pelvic Med Reconstr Surg (2011) 0.85

The minimum important difference for the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form in women with stress urinary incontinence. Neurourol Urodyn (2013) 0.85

Prevalence, management and impact of urinary incontinence in the workplace. Occup Med (Lond) (2005) 0.83

Lower urinary tract symptoms, quality of life and pelvic organ prolapse: irritative bladder and obstructive voiding symptoms in women planning to undergo abdominal sacrocolpopexy for advanced pelvic organ prolapse. J Urol (2007) 0.82

Recovery at home after major gynecologic surgery: how do our patients fare? Obstet Gynecol (2012) 0.82

Mindfulness-based stress reduction for treatment of urinary urge incontinence: a pilot study. Female Pelvic Med Reconstr Surg (2012) 0.81

Changed women: the long-term impact of vaginal mesh complications. Female Pelvic Med Reconstr Surg (2014) 0.79

The correlation of voiding variables between non-instrumented uroflowmetery and pressure-flow studies in women with pelvic organ prolapse. Neurourol Urodyn (2008) 0.79

Marketed vaginal mesh kits: rampant experimentation or improved quality of care? Thoughts following the 2006 AUGS meeting by AUGS president Ingrid Nygaard, M.D. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.78

Vaginal birth: a relic of the past in bulldogs and women? Obstet Gynecol (2011) 0.78

Should all women be offered elective cesarean delivery? Obstet Gynecol (2003) 0.78

Do Women Understand Urogynecologic Terminology? Female Pelvic Med Reconstr Surg (2011) 0.78

What does "FDA Approved" mean for medical devices? Obstet Gynecol (2008) 0.77

Urogynecology: the importance of long-term follow-up. Obstet Gynecol (2006) 0.75

The gold standard. Neurourol Urodyn (2009) 0.75

Surgery for pelvic organ prolapse--reply. JAMA (2013) 0.75

Cost-Effectiveness Analysis of Anticholinergics Versus Botox for Urgency Urinary Incontinence: Results From the Anticholinergic Versus Botox Comparison Randomized Trial. Female Pelvic Med Reconstr Surg (2016) 0.75

Giants in obstetrics and gynecology. Am J Obstet Gynecol (2016) 0.75

Words and their integral role in scientific research. Obstet Gynecol (2003) 0.75

Treatment of exercise incontinence with a urethral insert: a pilot study in women. Phys Sportsmed (2002) 0.75

Jay D. Iams, MD, AJOG Editor. Am J Obstet Gynecol (2016) 0.75

Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor Disorders. Female Pelvic Med Reconstr Surg (2017) 0.75

Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor Disorders. Female Pelvic Med Reconstr Surg (2017) 0.75